ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.

Alex A Adjei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.